Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver

Journal of Lipid Research

Volumn 40, Issue 10, 1999, Pages 1899-1910

  Yu, Kenneth C W ^a,b   Jiang, Yuan ^a   Chen, Wei ^a   Cooper, Allen D ^a,b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heparan sulfate proteoglycans; LDL receptor; LDL receptor related protein; Liver; Space of Disse

Indexed keywords

ASIALOFETUIN; CHYLOMICRON; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ISOLATED LIVER; LIPID ANALYSIS; LIVER FUNCTION; LIVER METABOLISM; LIVER PERFUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0032832824     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-2192.
2. Redgrave, T. G. 1970. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J. Clin. Invest. 49: 465-471.
3. Havel, R. J. 1995. Chylomicron remnants: hepatic receptors and metabolism. Curr. Opin. Lipidol. 6: 312-316.
4. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60: 473-485.
5. Karpe, F., G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten. 1994. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106: 83-97.
6. Weintraub, M. S., I. Grosskopf, T. Rassin, H. Miller, G. Charach, H. H. Rotmensch, M. Liron, A. Rubinstein, and A. Iaina. 1996. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. Br. Med. J. 312: 936-939.
7. Mahley, R. W., and M. M. Hussain. 1991. Chylomicron and chylomicron remnant catabolism. Curr. Opin. Lipidol. 2: 170-176.
8. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
9. Herz., J., U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, and K. K. Stanley. 1988. Surface location and high affinity for calcium of a 500 kD liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7: 4119-4127.
10. 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo. J. Biol. Chem. 268: 15804-15811.
11. de Faria, E., L. G. Fong, M. Komaromy, and A. D. Cooper. 1996. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J. Lipid Res. 37: 197-209.
12. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265: 17401-17404.
13. 2-macroglobulin. J. Biol. Chem. 266: 21232-21238.
14. Willnow, T. E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264: 1471-1474.
15. Rohlmann, A., M. Gotthardt, R. E. Hammer, and J. Herz. 1998. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms the role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101: 689-695.
16. Ishibashi, S., J. Herz, M. O. Maeda, J. L. Goldstein, and M. S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA. 91: 4431-4435.
17. Jong, C., V. E. H. Dahlmans, P. J. J. van Gorp, K. W. van Dijk, M. L. Breuer, M. H. Hofker, and L. M. Havekes. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98: 2259-2267.
18. Mortimer, B. C., D. J. Beveridge, I. J. Martins, and T. G. Redgrave. 1995. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. J. Biol. Chem. 270: 28767-28776.
19. Mokuno, H., S. Brady, L. Kotite, J. Herz, and R. J. Havel. 1994. Effect of the 39-kDa receptor-associated protein on the hepatic uptake and endocytosis of chylomicron remnants and low density lipoproteins in the rat. J. Biol. Chem. 269: 13238-13243.
20. Ji, Z-S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerariry, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
21. Ji, Z-S., S. Fazio, Y-L. Lee, and R. W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269: 2764-2772.
22. Ji, Z-S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparin sulfate proteoglycans. J. Lipid Res. 36: 583-592.
23. Williams, K. J., and I. V. Fuki. 1997. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr. Opin. Lipidol. 8: 253-262.
24. Cooper, A. D. 1977. The metabolism of chylomicron remnants by isolated perfused rat liver. Biochim. Biophys. Acta. 488: 464-474.
25. Cooper, A. D., and P. Y. S. Yu. 1978. Rates of removal and degradation of chylomicron remnants by isolated perfused rat liver. J. Lipid Res. 19: 635-643.
26. Nagata, Y., J. Chen, and A. D. Cooper. 1988. Role of low density lipoprotein receptor-dependent and -independent sites in binding and uptake of chylomicron remnants in rat liver. J. Biol. Chem. 263: 15151-15158.
27. Skottova, N., R. Savonen, A. Lookene, M. Hultin, and G. Olivecrona. 1995. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J. Lipid Res. 36: 1334-1344.
28. Redgrave, T. G., and G. Martin. 1977. Effects of chronic ethanol consumption on the catabolism of chylomicron triacylglycerol and cholesteryl ester in the rat. Atherosclerosis. 28: 69-80.
29. Ellsworth, J. L., F. B. Kraemer, and A. D. Cooper. 1987. Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J. Biol. Chem. 262: 2316-2325.
30. McFarlane, A. S. 1958. Efficient trace-labelling of proteins with iodine. Nature. 182: 53-57.
31. Kris-Etherton, P. M., and A. D. Cooper. 1980. Studies on the etiology of the hyperlipemia in rats fed an atherogenic diet. J. Lipid Res. 21: 435-442.
32. 2-macroglobulin (low density lipoprotein receptor-related protein) on rat parenchymal cells. J. Biol. Chem. 267: 17732-17737.
33. Kaplan, H. M., N. R. Brewer, and W. H. Blair. 1983. Physiology. In The Mouse in Biomedical Research. Academic Press, New York. 247-292.
34. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63: 601-637.
35. Strickland, D. K., M. Z. Kounnas, and W. S. Argraves. 1995. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9: 890-898.
36. Kita, T., J. L. Goldstein, M. S. Brown, Y. Watanabe, C. A. Hornick, and R. J. Havel. 1982. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 79: 3623-3627.
37. Rubinsztein, D. C., J. C. Cohen, G. M. Berger, D. R. van der Westhuyzen, G. A. Coetzee, and W. Gevers. 1990. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J. Clin. Invest. 86: 1306-1312.
38. Demacker, P. N. M., P. J. van Heijst, and F. H. Stalenhoef. 1992. A study of the chylomicron metabolism in WHHL rabbits after fat loading. Biochem. J. 276: 381-386.
39. Bowler, A., T. G. Redgrave, and J. C. L. Mamo. 1991. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Biochem. J. 276: 381-386.
40. Hussain, M. M., T. L. Innerarity, W. J. Brecht, and R. W. Mahley. 1995. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. J. Biol. Chem. 270: 8578-8587.
41. Mamo, J. C. L., D. Smith, K. C. W. Yu, A. Kawaguchi, M. HaradaShiba, T. Yamamura, and A. Yamamoto. 1998. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolemia. Eur. J. Clin. Invest. 28: 379-384.
42. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
43. Shafi, S., S. E. Brady, A. Bensadoun, and R. J. Havel. 1994. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35: 709-720.
44. Trevisan, A., F. Gudat, R. Guggenheim, G. Krey, V. Dunmuller, G. Luond, M. Duggelini, J. Laudmann, P. Tondelli, and L. Bianchi. 1982. Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscope. Hepatology. 2: 832-835.
45. Vassiliou, G., and K. K. Stanley. 1994. Exogenous receptor-associated protein binds to two distinct sites on human fibroblasts but does not bind to the glycosaminoglycan residues of heparin sulfate proteoglycans. J. Biol. Chem. 269: 15172-15178.
46. 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J. Biol. Chem. 267: 25764-25767.
47. Powell-Braxton, L., M. Veniant, R. D. Latvala, K. I. Hirano, W. B. Won, J. Ross, N. Dybdal, C. H. Zlot, S. G. Young, and N. O. Davidson. 1998. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein levels and severe atherosclerosis on a low-fat diet. Nat. Med. 4: 934-938.
48. Veniant, M. M., V. Pierotti, D. Newland, C. M. Cham, D. A. Sanan, and R. L. Walzern. 1997. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J. Clin. Invest. 100: 180-188.
49. Cabezas, M. C., T. W. de Bruin, H. E. Westerveld, E. Meijer, and D. W. Erkelens. 1998. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. J. Intern. Med. 244: 299-307.
50. Karpe, F., U. de Faire, M. Mercuri, M. G. Bond, M. L. Hellenius, and A. Hamsten. 1998. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis. 141: 307-314.
51. Karpe, F., T. Olivecrona, A. Hamsten, and M. Hultin. 1997. Chylomicron/chylomicron remnants turnover in humans: evidence for margination of chylomicrons and prior conversion of larger to smaller chylomicron remnants. J. Lipid Res. 38: 949-961.
52. Gianturco, S. H., M. P. Ramprasad, A. H. Y. Lin, R. Song, and W. A. Bradley. 1994. Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. J. Lipid Res. 35: 1674-1687.
53. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
54. Ji, Z-S., and R. W. Mahley. 1994. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein: further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14: 2025-2032.
55. Zsigmond, E., Y. Fuke, L. Li, K. Kobatashi, and L. Chan. 1998. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in apoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro. J. Lipid Res. 39: 1852-1861.
56. Sultan, F., D. E. Lagrange, H. Jansen, and S. Griglio. 1990. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim. Biophys. Acta. 1042: 150-152.
57. Windler, E., J. Greeve, H. Robenek, F. Rinninger, and H. Greten. 1996. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology. 24: 344-351.